VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$44.21
Market Cap
$3.53B
52W High
$46.00
52W Low
$29.45
ADV30
990,115
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
| Sep 2025 | 131,872,000 | 91,282,000 | 23,112,000 | 19,137,000 | 1,367,787,000 | 315,573,000 | 110,120,000 |
| Jun 2025 | 130,164,000 | 89,769,000 | 14,312,000 | -980,000 | 1,344,104,000 | 219,499,000 | 123,047,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$136,307,000
Investing CF
$-9,209,000
Financing CF
$-4,222,000
CapEx
$-9,677,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.83
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-377,630,000
Inventory
$20,546,000
Receivables
$44,660,000
ST Investments
$50,311,000
EBIT TTM
$61,937,000
Pretax Income TTM
$68,201,000
Interest Exp TTM
$0
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$541,742,976
EBITDA
$104,212,000
Free Cash Flow
$104,506,000
Enterprise Value
$3,193,335,808
Total Cash
$439,060,000
Total Debt
$39,333,000
Shares Out
79,792,647
Trailing EPS
$1.08
Book Value
$16.50
ROE
6.9%
ROA
3.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | — | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | — | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | — | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | — | 7,535,000 |
TTM Snapshot
Revenues TTM
$341,930,000
NetIncome TTM
$-37,315,000
OpCashFlow TTM
$0
Assets (Latest)
$1,300,035,000
Forward EPS
$1.91
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BLLN | BillionToOne, Inc. | $3.50B | $84.48 | — |
| OPCH | Option Care Health, Inc. | $3.35B | $21.35 | — |
| CON | Concentra Group Holdings Parent, Inc. | $3.27B | $25.53 | — |
| BKD | Brookdale Senior Living Inc. | $3.22B | $13.48 | — |
| NHC | NATIONAL HEALTHCARE CORP | $2.97B | $190.00 | — |
News headlines (Yahoo Finance, 1h cache)
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
2026-05-25 15:19 · Yahoo
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
2026-05-25 12:30 · Yahoo
Assessing Veracyte (VCYT) Valuation After Phase III Success For Prosigna And Decipher Cancer Tests
2026-05-23 17:11 · Yahoo
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
2026-05-22 12:00 · Yahoo
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
2026-05-21 22:00 · Yahoo
Veracyte to Participate in Upcoming Investor Conferences
2026-05-19 20:05 · Yahoo
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer
2026-05-15 13:00 · Yahoo
Statutory Profit Doesn't Reflect How Good Veracyte's (NASDAQ:VCYT) Earnings Are
2026-05-14 11:52 · Yahoo
Why Veracyte Stock Is Skyrocketing Higher This Week
2026-05-08 05:11 · Yahoo
Veracyte, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
2026-05-07 19:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.